Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma.

Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma.

Item
http://www.wikidata.org/entity/Q36926767
Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularizationProgress on antiangiogenic therapy for patients with malignant glioma.Experimental approaches for the treatment of malignant gliomas.Activation of abl family kinases in solid tumors.Comparative pharmacokinetic evaluation and bioequivalence study of three different formulations of Imatinib Mesylate in CML patientsExpression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas.Current and emerging molecular targets in glioma.Animal models for glioma drug discovery.Targeted therapy in gliomas.Investigational new drugs for brain cancer.Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles.
P2860

Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma.

Item
http://www.wikidata.org/entity/Q36926767
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Safety and pharmacokinetics of ...... adults with malignant glioma.
@en
type
label
Safety and pharmacokinetics of ...... adults with malignant glioma.
@en
prefLabel
Safety and pharmacokinetics of ...... adults with malignant glioma.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Safety and pharmacokinetics of ...... adults with malignant glioma.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932